Drug intelligence / Profile preview

alpha-lactalbumin + symbiotic

Development stage
Unknown
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

**Alpha-lactalbumin + symbiotic** is a combination product used primarily in infant formula and dietary supplements. This formulation typically includes **alpha-lactalbumin**, the major whey protein in human milk, and a **symbiotic** component (a mixture of probiotics and prebiotics). - **Alpha-lactalbumin** provides a high-quality source of essential amino acids—particularly rich in tryptophan—and may exert immunomodulatory, prebiotic, and antimicrobial effects. It supports infant growth and development and is used to improve the aminogram and reduce the total protein content of formulas, aiming to mimic human milk protein composition. - **Symbiotic supplementation** introduces both beneficial bacteria (probiotics, such as *Lactobacillus rhamnosus* and *Bifidobacterium* spp.) and prebiotic substrates (non-digestible ingredients that stimulate the growth of beneficial bacteria). This combination has been associated with improved gastrointestinal tolerance, positive modulation of the gut microbiota, increased fecal IgA, possible reduction in atopic dermatitis, and other gut-immune health benefits in infants[1][2]. - Mechanistically, the **probiotics** contribute to colonization resistance, immune modulation, and competitive exclusion of pathogens, while **prebiotics** provide fermentable substrates, resulting in increased production of short-chain fatty acids and support for the beneficial microbiome. - This combination is investigated mainly for its potential to support infant nutrition and wellbeing, reduce gastrointestinal symptoms, improve tolerance, and may have roles in reducing atopic dermatitis[1]. - Products may differ in the specific symbiotic components used (strain composition and prebiotic source).[1]

02

Targets

Zn2+ (Zinc ion)

Beyond the preview

Go deeper on alpha-lactalbumin + symbiotic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-lactalbumin + symbiotic.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call